Robotic Polypectomy Reimagined
Easy Endoscopic Removal
of Large and Flat Polyps



The Need
En-bloc removal of polyps within the gastrointestinal tract is not only crucial for treating colorectal cancer but also plays a preventative role, safeguarding against potential malignancies and addressing various other GI conditions.
Current approaches require a follow-up patient visit after the initial screening colonoscopy, leading to increased healthcare expenses, added complexity, and potential patient compliance issues.

In addition, today’s alternatives have substantial drawbacks:
Open or laparoscopic procedures
constitute major operations. They are complex, carry significant patient risks, and are very expensive.
EMR
(Endoscopic Mucosal Resection)
is incomplete for flat/large lesions, preventing margin assessment and may inadvertently disseminate malignant cells.
ESD
(Endoscopic Submucosal Dissection)
is challenging to perform, demands extensive training, and currently poses a heightened risk of complications, such as bleeding and perforations, requiring careful intraoperative management.
Open or laparoscopic procedures
constitute major operations. They are complex, carry significant patient risks, and are very expensive.
EMR
(Endoscopic Mucosal Resection)
is incomplete for flat/large lesions, preventing margin assessment and may inadvertently disseminate malignant cells.
ESD
(Endoscopic Submucosal Dissection)
is challenging to perform, demands extensive training, and currently poses a heightened risk of complications, such as bleeding and perforations, requiring careful intraoperative management.
Our Solution
MicroSteer provides an innovative solution for removing large or flat polyps in the gastrointestinal tract, delivering substantial benefits for patients and healthcare providers. The device is attached to most commercially available colonoscopes and uses off-the-shelf tools. Its accurate and automated cotrol enables precise dissection, facilitating effective en-bloc tissue removal for histopathological analysis.
Easy to Master
Streamline the procedure to make it intuitive and straightforward, much easier to learn and master than ESD.
Improved Efficacy
Accurate endoscopic tools and automation control enables precis dissection, facilitating effective en-bloc tissue removal for histopathological analysis.
Enhanced Safety
Precise control of the cutting tool minimizes overshoot and significantly reduces the risk of perforation.
Save $$$
Reduce lesion removal time and overall surgery duration. The option to combine the procedure during the screening colonoscopy may further save time and healthcare costs.
We’re setting a new standard in endoscopic procedures –
making advanced care more accessible and efficient for both patients and providers.
Overview
About

MicroSteer addresses a critical healthcare need of intraoperative removal of submucosal lesions.
MicroSteer Ltd. is developing a novel, semi-automated technology for complex polypectomies associated with EMR (Endoscopic Mucosal Resection) and ESD (Endoscopic Submucosal Dissection). MicroSteer’s device is the first steered polypectomy device, enabling endoscopists a safer and faster procedure, currently executed only by highly experienced interventional gastroenterologists. The technology facilitates a range of adjustable cutting devices moving along a pre-defined, programmed exact track.

Management Team
Ofer Pillar
Eyal Ben-Esti
Adi Strauss
Scientific Advisory Board
Dr. Amyn Haji
- Consultant Colorectal & Laparoscopic
- Surgeon at King’s College Hospital, London
- Lead for Complex Polyps and Early Cancer
Dr. Sergei Vosko
- Director of Endoscopy Unit, Hadassah Medical Center
- Founder of the Advanced Endoscopic Resection Unit at Shamir Medical Center
- Training in Advanced Endoscopy in Westamide Hospital, Sydney
Prof. Ken Ohata
- Chief Gastroenterology and Director of the Endoscopy Center at NTT, Medical Center Tokyo
- Over 15 years of ESD experience and ~3,500 procedures performed
Dr. Ari Benson
- Director of Endoscopy Unit, Shaare Zedek Medical Center
- Fellowship in Advanced Endoscopy, Hadassah Medical Center
- ESD training in Kobe, Japan
Intellectual Property
MicroSteer is committed to safeguarding its intellectual property, actively seeking patent protection across major global markets. The products and patent numbers listed below represent a substantial portion of our portfolio but may not encompass all pending or granted patents. We continue to advance additional patents that are currently under review. For further details on granted patents and published U.S. patent applications, please visit the United States Patent and Trademark Office website. Published international patent applications may be viewed at the World Intellectual Property Organization website.
EP4061256A1
Systems and Methods for Controllable Access of Tools to Elevated Tissues This patent describes a medical device that assists endoscopist access and treat raised tissues, such as polyps or tumors. It works by placing a special rail near the targeted tissue inside the body. A small robotic vehicle, carrying surgical tools like a knife, moves along this rail, allowing doctors to reach and operate different sides of the tissue without needing to reposition their instruments manually. This approach aims to make procedures less invasive and more accurate, improving outcomes for patients.
News
6-March-2025
MicroSteer Receives European Patent Allowance for Innovative Polypectomy Technology
MicroSteer is proud to announce that the European Patent Office has issued a Notice of Allowance for the first of our core patents, marking a significant milestone in the protection of our groundbreaking technology for endoscopic polyp removal. This strengthens MicroSteer’s intellectual property portfolio and reinforces our commitment to revolutionizing minimally invasive endoscopic procedures across Europe. The allowance paves the way for broader adoption of our advanced solutions, furthering our mission to empower clinicians and improve patient outcomes in digestive health.
4-Apr-2025
MicroSteer Takes 3rd Place in Fan Favorite at 2025 AGA Tech Summit Shark Tank!
MicroSteer is proud to share its remarkable achievement at the 2025 AGA Tech Summit Shark Tank in Chicago. As a finalist in this prestigious event, our CEO, Eyal Ben Esti, showcased our groundbreaking technology designed to revolutionize endoscopic polypectomy. The presentation captivated both the esteemed panel and the live audience, securing MicroSteer 3rd place in the Fan Favorite category! This honor highlights the transformative potential of our innovation in enhancing patient care and shaping the future of polyp removal procedures.